Fresenius reported 1.4B in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Akzo Nobel AKZA:NA 708M 25M
Alcon AG ALC:SW 783M 91M
AstraZeneca AZN:LN 2.57B 76M
BASF BAS:GR 2.43B 199M
Bayer BAYN:GR 3.75B 226M
Davita Healthcare Partners DVA:US $ 298.09M 16.66M
E.ON EOAN:GR 1.42B 22M
Fresenius FRE:GR 1.4B 134M
Fresenius Medical Care FMS:US 830M 118.48M
Fresenius Medical Care FME:GR 830M 118M
Getinge GETIB:SS 1.75B 50M
Givaudan GIVN:VX 536M 20M
GlaxoSmithKline GSK:LN 2.5B 183M
GN Store Nord GN:DC 1.11B 18M
GRIFOLS GRF:SM 249.86M 7.28M
Hikma Pharmaceutical HIK:LN 232M 3M
Merck MRK:GR 1.34B 62M
Novartis NOVN:VX 3.71B 190M
Philips PHIA:NA 1.19B 35M
William Demant Holding WDH:DC 4.48B 503M